863 Tralokinumab (CAT-354), an Interleukin 13 Antibody, in Moderate to Severe Ulcerative Colitis: A Phase 2A Randomized Placebo-Controlled Study
Gastroenterology(2014)
Key words
Inflammation,Ulcerative Colitis
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined